Ghanaians urged to be mindful of Escherichia

Tamale, Sept 9. – Dr Enoch Harvoh, Medical Officer of obstetrics and gynecology at Tamale Teaching Hospital (TTH) urged Ghanaians especially nursing mothers and health professionals to be mindful of their hygiene to reduce the rate of Escherichia Coli infection spread among families. He said Escherichia Coli is also known as E. Coli is a…

Read More
AstraZeneca

AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity

AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and postdoctoral researchers from across the world to propose their innovative ideas to help accelerate drug discovery…

Read More
AstraZeneca

New AstraZeneca COVID-19 vaccine data further support its use as third dose booster

Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S [Recombinant]), when given as a third dose booster, increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants, while a separate analysis of samples from the trial showed increased antibody response to the…

Read More
COVID-19 Vaccine AstraZeneca

COVID-19 Vaccine AstraZeneca significantly boosted antibody levels against Omicron

University of Oxford study supports use of COVID-19 Vaccine AstraZeneca as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of COVID-19 Vaccine AstraZeneca were broadly similar to levels achieved after two doses against the Delta variant. AstraZeneca’s Vaxzevria (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron…

Read More